Travel Restrictions, Delays in Customer Acceptance and Business Impact Due to COVID-19
First written in FY2020. 8 of 13 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2024: 5 of 22 companies on the "Worse" side.
13 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「There were no significant changes to the assumptions described in the additional information section of the securities report for the previous consolidated fiscal year.」
Disclosure continued to state that there were no significant changes to the assumptions described in the additional information for the previous fiscal year. - FY2024Easing of restrictions on movement and the continuing impact of the pandemicAnnual report
「Although it remains difficult to accurately predict when COVID-19 will subside, given that many countries, including Japan, are easing restrictions to resume economic activity, we have assumed that restrictions on the movement of people will be eased during the next consolidated fiscal year and have made accounting estimates concerning impairment of property, plant and equipment and the recoverability of deferred tax assets.」
While assuming the easing of restrictions to resume economic activity and the easing of restrictions on movement during the following fiscal year, the timing of the infection's subsiding remains difficult to predict, and the possibility of an impact on accounting estimates continues. - FY2024-Q3RestatedAnnual report
「Although COVID-19 was reclassified as a Category 5 disease under the Infectious Diseases Control Law in May 2023, there were no significant changes to the assumptions concerning its impact described in the additional information section of the securities report for the previous consolidated fiscal year.」
It was stated that there were no significant changes to the assumptions concerning the impact of COVID-19 described in the previous fiscal year, even after the reclassification as a Category 5 disease under the Infectious Diseases Control Law. - FY2024-Q2RestatedAnnual report
「Although COVID-19 was reclassified as a Category 5 disease under the Infectious Diseases Control Law in May 2023, there were no significant changes to the assumptions concerning its impact described in the additional information section of the securities report for the previous consolidated fiscal year.」
It was stated that there were no significant changes to the assumptions concerning the impact of the infection described in the previous fiscal year, even after the reclassification as a Category 5 disease under the Infectious Diseases Control Law. - FY2024-Q1Economic recovery trend following the easing of restrictions on activitiesAnnual report
「Although the Japanese economy has been affected by longer parts delivery lead times and higher resource prices, economic activity has shown a gradual recovery as the reclassification of COVID-19 as a Category 5 disease under the Infectious Diseases Control Law led to the easing of restrictions on activities, and conditions are emerging in which companies are reconsidering capital investment.」
It was stated that the economy was gradually recovering and companies were beginning to reconsider capital investment following the reclassification of COVID-19 as a Category 5 disease and the easing of restrictions on activities. Meanwhile, longer parts delivery lead times and higher resource prices continued. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described under “Additional Information” in the securities report for the previous consolidated fiscal year.」
Disclosure continued to state that there were no significant changes to the assumptions concerning the impact of the spread of COVID-19 made in the previous fiscal year. - FY2023-Q2Signs of easing pandemic-related effects and concerns over a resurgenceAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described under “Additional Information” in the securities report for the previous consolidated fiscal year.」
Although there were no significant changes to the assumptions concerning the impact of the infection, the spread of COVID-19 in the operating environment showed signs of slowing, while concern remained over a renewed increase. - FY2023-Q1RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described under “Additional Information” in the securities report for the previous consolidated fiscal year.」
The disclosure that there were no significant changes to the assumptions concerning the impact of the spread of COVID-19 made in the previous fiscal year continued. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described under “Additional Information” in the securities report for the previous consolidated fiscal year.」
The disclosure that there were no significant changes to the assumptions concerning the impact of the spread of COVID-19 made in the previous fiscal year continued. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described under “Additional Information” in the securities report for the previous consolidated fiscal year.」
It was disclosed that there were no significant changes to the assumptions concerning the impact of the spread of COVID-19 made in the previous fiscal year, indicating that the risk remains recognized. - FY2021-Q3RestatedAnnual report
「Economic activity stagnated as the global spread of COVID-19 led countries to implement measures such as lockdowns and requests to refrain from travel」
The global spread of COVID-19 and the resulting stagnation of economic activity caused by lockdowns and requests to refrain from travel continued. - FY2021-Q1WorsenedAnnual report
「Economic activity stagnated as the global spread of COVID-19 led countries to implement measures such as lockdowns and requests to refrain from travel」
The global spread of COVID-19 and the stagnation of economic activity caused by lockdowns and requests to refrain from travel continued and became more pronounced in the operating environment during the quarter. - FY2020First statedAnnual report
「As the spread of COVID-19 restricted the movement of people, customer acceptance procedures were delayed, resulting in effects including delays in the timing of revenue recognition.」
Restrictions on movement due to COVID-19, delays in customer acceptance and delays in the timing of revenue recognition were identified as new risks, and actual effects arose during the current consolidated fiscal year.